Leogenix LLC – Trademark Portfolio

Entity Type: 16

Leogenix LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 34 (Smokers Articles) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include RAKTINE, SERABEL, and LEOGENIX. The owner is based in Burbank, CA.

2920 West Olive Ave, Suite 111

Burbank, CA 91505

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DOZZA
DOZZA
Abandoned 2022
SERABEL
SERABEL
Registered 2020
RAKTINE
RAKTINE
Registered 2020
LEOGENIX
LEOGENIX
Registered 2020

Trademark Classifications

Leogenix LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

34
Smokers Articles (1 filing)

Tobacco; smokers articles; matches

Frequently Asked Questions

How many trademarks does Leogenix LLC have?

Leogenix LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does Leogenix LLC file in?

Leogenix LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 34 (Smokers Articles). Class 35 covers advertising; business management; business administration; office functions.

What are Leogenix LLC's most well-known trademarks?

Leogenix LLC's registered trademark portfolio includes well-known marks such as RAKTINE, SERABEL, and LEOGENIX. These are among 3 currently registered trademarks in the portfolio.

What is Leogenix LLC's trademark registration success rate?

Leogenix LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.